BE1002504A3 - Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. - Google Patents

Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. Download PDF

Info

Publication number
BE1002504A3
BE1002504A3 BE8900463A BE8900463DA BE1002504A3 BE 1002504 A3 BE1002504 A3 BE 1002504A3 BE 8900463 A BE8900463 A BE 8900463A BE 8900463D A BE8900463D A BE 8900463DA BE 1002504 A3 BE1002504 A3 BE 1002504A3
Authority
BE
Belgium
Prior art keywords
hecogenin
benign prostatic
prostatic hyperplasia
treatment
esters
Prior art date
Application number
BE8900463A
Other languages
English (en)
Inventor
August S Muehlweg Streber
Original Assignee
Kanoldt Arzneimittel Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanoldt Arzneimittel Gmbh filed Critical Kanoldt Arzneimittel Gmbh
Application granted granted Critical
Publication of BE1002504A3 publication Critical patent/BE1002504A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

L'invention concerne une préparation médicamenteuse à base d'ester d'hécogénine et de supports pharmaceutiquement compatibles. La préparation médicamenteuse agit en inhibant la croissance cellulaire et peut être mise en oeuvre pour le traitement causal de l'hyperplasie prostatique bénigne chez l'homme et l'animal.
BE8900463A 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne. BE1002504A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3838716A DE3838716A1 (de) 1988-11-15 1988-11-15 Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie

Publications (1)

Publication Number Publication Date
BE1002504A3 true BE1002504A3 (fr) 1991-03-05

Family

ID=6367236

Family Applications (2)

Application Number Title Priority Date Filing Date
BE8900463A BE1002024A6 (fr) 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
BE8900463A BE1002504A3 (fr) 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BE8900463A BE1002024A6 (fr) 1988-11-15 1989-04-26 Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.

Country Status (9)

Country Link
US (1) US5002939A (fr)
EP (1) EP0369216B1 (fr)
JP (1) JP2562210B2 (fr)
AT (1) ATE90563T1 (fr)
BE (2) BE1002024A6 (fr)
DE (2) DE3838716A1 (fr)
ES (1) ES2057054T3 (fr)
GR (1) GR3008170T3 (fr)
IT (1) IT1229272B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1198622C (zh) * 1998-03-26 2005-04-27 植物药物公共有限公司 用于治疗阿尔茨海默病的甾类皂苷及其衍生物
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6241987B1 (en) * 1998-08-20 2001-06-05 Amway Corporation Dietary supplement containing saw palmetto, pumpkin seed, and nettle root
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
KR101130212B1 (ko) * 2002-03-27 2012-04-13 파이토팜 피엘씨 사포게닌 및 그 유도체의 치료 방법 및 사용법
CN102066397B (zh) 2008-04-18 2013-09-11 里亚塔医药公司 包含抗炎症药效团的化合物以及使用方法
WO2018042825A1 (fr) * 2016-08-30 2018-03-08 パナソニックＩｐマネジメント株式会社 Élément de conversion de couleur

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA582813A (fr) * 1959-09-08 Elks Joseph 3.beta., 12.beta.-DIHYDROXY-11-OXO-23-BROMO-5.alpha., 22.alpha.-SPIROSTAN
CA985172A (en) * 1972-10-06 1976-03-09 Dushan M. Dvornik Compositions and methods for reducing blood cholesterol
US3935194A (en) * 1974-01-22 1976-01-27 Omni Research Incorporated Separation of hecogenin-tigogenin mixtures
DE2759171A1 (de) * 1977-12-31 1979-07-12 Roecar Holdings Nv Arzneimittel mit wirkung als prostaglandinsynthetaseninhibitor
DE2926463A1 (de) * 1978-07-05 1980-01-24 Roecar Holdings Nv Spiroketaline und ihre verwendung
GB2024624A (en) * 1978-07-05 1980-01-16 Roecar Holdings Nv Anti inflammatory spiroketalins
DE3888378T2 (de) * 1987-04-03 1994-09-29 Merck & Co Inc Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen.

Also Published As

Publication number Publication date
EP0369216B1 (fr) 1993-06-16
JPH02180830A (ja) 1990-07-13
ES2057054T3 (es) 1994-10-16
US5002939A (en) 1991-03-26
BE1002024A6 (fr) 1990-05-22
GR3008170T3 (fr) 1993-09-30
IT8920466A0 (it) 1989-05-11
DE58904722D1 (de) 1993-07-22
ATE90563T1 (de) 1993-07-15
IT1229272B (it) 1991-07-26
DE3838716C2 (fr) 1990-09-20
EP0369216A3 (en) 1990-11-07
EP0369216A2 (fr) 1990-05-23
DE3838716A1 (de) 1990-05-17
JP2562210B2 (ja) 1996-12-11

Similar Documents

Publication Publication Date Title
BE1002504A3 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
EP0252290A3 (en) Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
DK0640336T3 (da) Parenterale præparater til vedvarende frigivelse indeholdende polyglyceroldiestere
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
FR2635265B1 (fr) Composition pharmaceutique intraveineuse comprenant de la cyclosporine en tant que principe actif et procede pour sa preparation
MY101593A (en) Sustained release preparation.
RU94033520A (ru) Впрыскиваемый лецитиновый гель
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
DE69434418D1 (de) Orale Dareichungsform
BR9501404A (pt) 1H-indol-3 glioxilamida e formulação farmacèutica
NO940277L (no) Triglycerider og blandinger av slike
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
BE1003009A5 (fr) Nouvelles compositions pharmaceutiques a base de cyclosporines.
FI904395A0 (fi) 4-hydroxitetrahydropyran-2-oner samt motsvarande dihydroxikarboxylsyra derivat, salter och estrar, foerfarande foer deras framstaellning, deras anvaendning saosom laekemedel, farmaceutiska produkter samt foerprodukter.
MY106038A (en) 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents.
NO176082C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat inneholdende bunazosin, for perkutan tilförsel
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
ES2114851T3 (es) Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas.
WO1987004926A3 (fr) Procede permettant de modifier la structure lipidique des membranes cellulaires et compositions pharmaceutiques utilisees a cet effet
ATE80295T1 (de) Fettsaeure und cyclosporin enthaltende zusammensetzung mit ermaessigter nephrotoxizitaet.
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
IL88403A0 (en) Esters of pharmacologically active carboxylic acids,their manufacture and pharmaceutical compositions containing them
IT8820172A0 (it) Ammidi di acidi ciclometilen_1,2_dicarbossilici adattivita' terapeutica, procedimenti per la loro preparazione e composizioni farmaceutiche che le contengono.
SE8600496L (sv) Farmaceutiska kompositioner innehallande 9,10-dihydroergotalkaloider
BE887639A (fr) Compositions pharmaceutiques pour le traitement de l'hyperplasie prostatique benigne

Legal Events

Date Code Title Description
RE Patent lapsed

Effective date: 20060430